Amplifon S.p.A Total Non-Operating Income/Expense 2019-2024 | AMFPF

Amplifon S.p.A total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.038B, a 58.14% increase year-over-year.

  • Amplifon S.p.A annual total non-operating income/expense for 2024 was $-0.065B, a 21.34% increase from 2023.
  • Amplifon S.p.A annual total non-operating income/expense for 2023 was $-0.054B, a 45.46% increase from 2022.
  • Amplifon S.p.A annual total non-operating income/expense for 2022 was $-0.037B, a 37.41% increase from 2021.

Amplifon S.p.A Total Non-Operating Income/Expense 2019-2024 | AMFPF

  • Amplifon S.p.A annual total non-operating income/expense for 2024 was $-0.065B, a 21.34% increase from 2023.
  • Amplifon S.p.A annual total non-operating income/expense for 2023 was $-0.054B, a 45.46% increase from 2022.
  • Amplifon S.p.A annual total non-operating income/expense for 2022 was $-0.037B, a 37.41% increase from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$141.7B
CVS Health (CVS)$78.2B
Elevance Health (ELV)$66.8B
Cencora (COR)$56.9B
DiDi Global (DIDIY)$28B
Labcorp Holdings (LH)$21B
Natera (NTRA)$18.8B
BioMerieux (BMXMF)$16B
EUROFINS SCIENT (ERFSF)$14.7B
ICON (ICLR)$13.6B
CochLear (CHEOY)$13.5B
Solventum (SOLV)$12.9B
Medpace Holdings (MEDP)$12.3B
Revvity (RVTY)$11.7B
Viatris (VTRS)$11B
Avantor (AVTR)$9.3B
Sonic Healthcare (SKHHY)$9.1B
HealthEquity (HQY)$8.4B
Charles River Laboratories (CRL)$8.2B
Caris Life Sciences,�Inc (CAI)$7.6B
Bausch + Lomb (BLCO)$5B
BrightSpring Health Services (BTSG)$3.7B
Sotera Health (SHC)$3.4B
Surgery Partners (SGRY)$2.8B
Organon (OGN)$2.6B
Concentras Parent (CON)$2.6B
Alignment Healthcare (ALHC)$2.5B
GeneDx Holdings (WGS)$2.4B
Progyny (PGNY)$2B
PACS (PACS)$1.8B